Evidence map›Paper›PMID 37303421›Full record

ReviewCureus2023

Canine Scent Detection in Lung Cancer Screening.

Megan Kudlak, Mohammed Mohammed Ali, Sarah Whitlow Kirk, Noah Medalsy, Heather Yoder, Harleen Bhullar

Abstract readReview
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Megan KudlakAlumni, American University of the Caribbean School of Medicine, Cupecoy, SXM.
Mohammed Mohammed AliMedicine, American University of the Caribbean School of Medicine, Cupecoy, SXM.
Sarah Whitlow KirkMedicine, American University of the Caribbean School of Medicine, Cupecoy, SXM.
Noah MedalsyMedicine, American University of the Caribbean School of Medicine, Cupecoy, SXM.
Heather YoderMedicine, American University of the Caribbean School of Medicine, Cupecoy, SXM.
Harleen BhullarMedicine, American University of the Caribbean School of Medicine, Cupecoy, SXM.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Canines historically have been proven to have great benefits in human medicine. They have a unique ability to detect volatile organic compounds, or VOCs, in several different diseases, which allows them to work efficiently as a medical alert dog or detect the presence of certain diseases in human samples. Early studies have shown efficiency in the ability of canines to detect malignant cells from primary lung tumors in the fluid and breath samples of patients. Lung cancer is the third most common cancer and is the number one cause of cancer-related deaths in the United States. Because of its commonality, The U.S. Preventive Services Task Force developed guidelines for screening high-risk individuals, which includes low-dose CT with proven efficacy. Although effective, it comes with limitations, including increased cost, concern for radiation exposure, and low compliance amongst those who are eligible for screening. Other screening methods have been studied to overcome these deficiencies, including the use of canines trained in medical scent detection. Medical scent canines may prove to be an efficient alternative form of screening to the traditional use of low-dose CT and may be a viable non-imaging screening alternative.

Indexed as

cancer screeningcanine scent detectioncanines in medicinelung cancerlung cancer screeningmedical canines

Identifiers

PMID37303421
PMCPMC10257358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.